These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9324287

  • 1. Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents.
    Antoku K, Liu Z, Johnson DE.
    Leukemia; 1997 Oct; 11(10):1665-72. PubMed ID: 9324287
    [Abstract] [Full Text] [Related]

  • 2. The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.
    Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, Auer B, Kofler R.
    FEBS Lett; 1997 Jan 27; 402(1):36-40. PubMed ID: 9013854
    [Abstract] [Full Text] [Related]

  • 3. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
    Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH.
    Blood; 1997 Aug 01; 90(3):935-43. PubMed ID: 9242521
    [Abstract] [Full Text] [Related]

  • 4. Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses.
    Macen J, Takahashi A, Moon KB, Nathaniel R, Turner PC, Moyer RW.
    J Virol; 1998 May 01; 72(5):3524-33. PubMed ID: 9557631
    [Abstract] [Full Text] [Related]

  • 5. IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells.
    Antoku K, Liu Z, Johnson DE.
    Leukemia; 1998 May 01; 12(5):682-9. PubMed ID: 9593265
    [Abstract] [Full Text] [Related]

  • 6. CrmA/SPI-2 inhibition of an endogenous ICE-related protease responsible for lamin A cleavage and apoptotic nuclear fragmentation.
    Takahashi A, Musy PY, Martins LM, Poirier GG, Moyer RW, Earnshaw WC.
    J Biol Chem; 1996 Dec 20; 271(51):32487-90. PubMed ID: 8955067
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 8. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.
    Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM.
    Cell; 1995 Jun 02; 81(5):801-9. PubMed ID: 7774019
    [Abstract] [Full Text] [Related]

  • 9. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA.
    Geley S, Hartmann BL, Kofler R.
    FEBS Lett; 1997 Jan 02; 400(1):15-8. PubMed ID: 9000505
    [Abstract] [Full Text] [Related]

  • 10. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).
    Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM.
    Blood; 1997 Oct 15; 90(8):3118-29. PubMed ID: 9376593
    [Abstract] [Full Text] [Related]

  • 11. Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.
    Datta R, Banach D, Kojima H, Talanian RV, Alnemri ES, Wong WW, Kufe DW.
    Blood; 1996 Sep 15; 88(6):1936-43. PubMed ID: 8822910
    [Abstract] [Full Text] [Related]

  • 12. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.
    Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ.
    J Clin Invest; 1999 Jan 15; 103(1):137-45. PubMed ID: 9884343
    [Abstract] [Full Text] [Related]

  • 13. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8.
    Takahashi A, Hirata H, Yonehara S, Imai Y, Lee KK, Moyer RW, Turner PC, Mesner PW, Okazaki T, Sawai H, Kishi S, Yamamoto K, Okuma M, Sasada M.
    Oncogene; 1997 Jun 12; 14(23):2741-52. PubMed ID: 9190889
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

  • 15. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S, Hartmann BL, Hattmannstorfer R, Löffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EM, Ebner M, Auer B, Kofler R.
    Oncogene; 1997 Nov 13; 15(20):2429-37. PubMed ID: 9395239
    [Abstract] [Full Text] [Related]

  • 16. Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells.
    MacFarlane M, Cain K, Sun XM, Alnemri ES, Cohen GM.
    J Cell Biol; 1997 Apr 21; 137(2):469-79. PubMed ID: 9128256
    [Abstract] [Full Text] [Related]

  • 17. Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis.
    Chen RH, Chang TY.
    Cell Growth Differ; 1997 Jul 21; 8(7):821-7. PubMed ID: 9218876
    [Abstract] [Full Text] [Related]

  • 18. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
    Schmitt E, Steyaert A, Cimoli G, Bertrand R.
    Cell Death Differ; 1998 Jun 21; 5(6):506-16. PubMed ID: 10200502
    [Abstract] [Full Text] [Related]

  • 19. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM, Huang Y, Fang G, Bhalla K.
    Cell Growth Differ; 1996 Aug 21; 7(8):1087-94. PubMed ID: 8853905
    [Abstract] [Full Text] [Related]

  • 20. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death.
    Robertson NM, Zangrilli J, Fernandes-Alnemri T, Friesen PD, Litwack G, Alnemri ES.
    Cancer Res; 1997 Jan 01; 57(1):43-7. PubMed ID: 8988038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.